Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × Clarithromycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 17 Lymphoma, B-Cell, Marginal Zone 6 Stomach Neoplasms 4 Lymphoma 4 Neoplasms, Plasma Cell 3 Dyspepsia 3 Recurrence 2 Peptic Ulcer 2 Gastritis 2 Skin Neoplasms 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms 1 Persistence of Infection With Helicobacter Pylori 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, B-Cell 1 Infections 1 Helicobacter Infections 1 Familial primary gastric lymphoma 1 Chemotherapy Effect 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Appendiceal Neoplasms 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 6 Fluconazole 3 Daptomycin 3 Antibiotic Prophylaxis 3 gamma-Globulins 2 Voriconazole 2 Vancomycin 2 Ribavirin 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Cyclophosphamide 2 Cefazolin 2 Amoxicillin-Potassium Clavulanate Combination 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1 lime 1 idecabtagene vicleucel 1 golimumab 1 gilteritinib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02624440 2015-12-08

SUTRICA

Aalborg University Hospital

Phase 2 Unknown

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡